Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
GC Corp.
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
GC Genome to Present New Data at AACR 2024
2024-03-25 21:00
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024
2024-02-14 16:33
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)
2024-01-23 11:53
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
2023-12-18 09:49
GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia
2023-12-06 08:56
GC Biopharma establishes mRNA production facility in Hwasun, Korea
2023-12-01 16:31
GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023
2023-11-20 14:39
GC Genome Enters License Agreement with MP Group
2023-11-10 13:00
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval
2023-11-06 09:11
GC Cell Joins U.S Cancer Moonshot Project
2023-10-25 11:27
GC Genome to Present the Latest Lung Cancer Diagnostic Tool at ESMO 2023
2023-10-20 13:10
GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023
2023-10-11 08:49
GC Biopharma Signs Power Purchase Agreement with SK E&S
2023-10-10 14:20
FDA Grants Orphan Drug Designation to GC Biopharma's Drug Candidate for Thrombotic Thrombocytopenic Purpura
2023-10-06 08:12
GCCL to be the first in the industry sector to adopt Lab Information Management System (LIMS)
2023-09-05 09:57
GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community
2023-08-30 16:05
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics
2023-08-25 15:14
Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements.
2023-08-18 08:58
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid)
2023-07-31 13:20
GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients
2023-07-27 08:53
1
2
3